Join
Live feed
·
INSIDERFilingvia Quantisnow
Entero Therapeutics Inc. logo

Chief Financial Officer Romano Sarah sold $664 worth of shares (621 units at $1.07), decreasing direct ownership by 3% to 18,490 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ENTO· Entero Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENTO (Entero Therapeutics Inc.) and more on Quantisnow.